TY - JOUR
KW - Opioid
KW - Adolescent
KW - buprenorphine
KW - pediatric
KW - primary care
AU - Sharon Levy
AU - Shannon Mountain-Ray
AU - Jason Reynolds
AU - Steven J. Mendes
AU - Jonas Bromberg
A1 - 
AB - BACKGROUND: Medication treatment for opioid use disorder is effective, and is recommended for adolescents, although very few adolescents with opioid use disorder ever receive medications. Reasons include lack of trained medication prescribers for this age group and difficulty in identifying adolescents with substance use disorders. This paper examines a novel implementation model of identifying and providing treatment for substance use disorders, including opioid use disorder, in a pediatric primary care practice. METHODS: Patients presenting to a selected primary care pediatrics practice for any reason between March 9, 2017, and July 24, 2017, who were identified by screening, self-report, or other clinical information to have a substance use problem were referred to an integrated clinical social worker for treatment. The authors recorded the number of patients who were referred, number of visits completed, and substance use disorder and mental health diagnoses. RESULTS: In the first 4 months of this program, 683 patients aged 12-22 completed a health maintenance appointment; 20 were referred for substance use disorder treatment and 13 completed at least 1 substance use disorder treatment visit with the integrated clinical social worker. The mean number of visits completed was 5.3. Three patients with opioid use disorders were identified, and 2 were induced on buprenorphine. CONCLUSIONS: The current model for treatment of substance use disorders, including opioid use disorders, was feasible and acceptable in a pediatric primary care practice. Broadly implemented, such a model could substantially increase access to substance use disorder treatment for adolescents and young adults.
AD - a Department of Medicine , Boston Children's Hospital , Boston , Massachusetts , USA.; b Harvard Medical School , Boston , Massachusetts , USA.; c Pediatric Physicians Organization at Children's Hospital , Boston , Massachusetts , USA.; a Department of Medicine , Boston Children's Hospital , Boston , Massachusetts , USA.; c Pediatric Physicians Organization at Children's Hospital , Boston , Massachusetts , USA.; d Wareham Pediatric Associates , Wareham , Massachusetts , USA.; c Pediatric Physicians Organization at Children's Hospital , Boston , Massachusetts , USA.; d Wareham Pediatric Associates , Wareham , Massachusetts , USA.; c Pediatric Physicians Organization at Children's Hospital , Boston , Massachusetts , USA.; d Wareham Pediatric Associates , Wareham , Massachusetts , USA.; b Harvard Medical School , Boston , Massachusetts , USA.; c Pediatric Physicians Organization at Children's Hospital , Boston , Massachusetts , USA.; d Wareham Pediatric Associates , Wareham , Massachusetts , USA.; e Department of Psychiatry , Boston Children's Hospital , Boston , Massachusetts , USA.
BT - Substance abuse
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - United States
DO - 10.1080/08897077.2018.1455165
JF - Substance abuse
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Medication treatment for opioid use disorder is effective, and is recommended for adolescents, although very few adolescents with opioid use disorder ever receive medications. Reasons include lack of trained medication prescribers for this age group and difficulty in identifying adolescents with substance use disorders. This paper examines a novel implementation model of identifying and providing treatment for substance use disorders, including opioid use disorder, in a pediatric primary care practice. METHODS: Patients presenting to a selected primary care pediatrics practice for any reason between March 9, 2017, and July 24, 2017, who were identified by screening, self-report, or other clinical information to have a substance use problem were referred to an integrated clinical social worker for treatment. The authors recorded the number of patients who were referred, number of visits completed, and substance use disorder and mental health diagnoses. RESULTS: In the first 4 months of this program, 683 patients aged 12-22 completed a health maintenance appointment; 20 were referred for substance use disorder treatment and 13 completed at least 1 substance use disorder treatment visit with the integrated clinical social worker. The mean number of visits completed was 5.3. Three patients with opioid use disorders were identified, and 2 were induced on buprenorphine. CONCLUSIONS: The current model for treatment of substance use disorders, including opioid use disorders, was feasible and acceptable in a pediatric primary care practice. Broadly implemented, such a model could substantially increase access to substance use disorder treatment for adolescents and young adults.
PP - United States
PY - 2018
SN - 1547-0164; 0889-7077
SP - 1
EP - 9
EP - 
T1 - A novel approach to treating adolescents with opioid use disorder in pediatric primary care
T2 - Substance abuse
TI - A novel approach to treating adolescents with opioid use disorder in pediatric primary care
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 29595410
U3 - 10.1080/08897077.2018.1455165
VO - 1547-0164; 0889-7077
Y1 - 2018
Y2 - Mar 29
ER -